Preclinical
N/A
Sponsors / Collaborators
Baylor College of Medicine, Epilepsy Research Foundation, NIH-NINDS (NS039941)
Preclinical
N/A
Sponsors / Collaborators
Baylor College of Medicine, NIH-NINDS (NS39941), Epilepsy Foundation (EF)
Phase 2
N/A
Sponsors / Collaborators
Seoul National University Hospital
Sponsors / Collaborators
The University of Queensland, Australia, Epilepsy Therapy Project
Phase 2
N/A
Sponsors / Collaborators
Ultragenyx; Adrian Lacy, Cook Children's
Preclinical
N/A
Sponsors / Collaborators
Neuroene Therapeutics
Sponsors / Collaborators
University of San Diego
New Formulations and Indications
Convection Enhanced Delivery of Anticonvulsant Toxins for the Treatment of Intractable Partial Epilepsy
Preclinical
N/A
Sponsors / Collaborators
University of California Davis; Medgenesis Therapeutix, Epilepsy Foundation (EF)
Sponsors / Collaborators
Cerebral Therapeutics, EF
Disclaimer
The Epilepsy Foundation makes no claims of accuracy of the following data. Although every effort is made to continuously update this list, some errors are inevitable. Companies or academicians or others who are directly involved with any of the therapies listed here are strongly encouraged to keep us updated by contacting contactus@efa.org of any needed changes.